We are live on ! Find out more
KA

Klingman & Associates Portfolio holdings

AUM $2.35B
1-Year Est. Return 23.18%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+23.18%
3 Year Est. Return
+59.34%
5 Year Est. Return
+62.44%
10 Year Est. Return
+178.86%
AUM
$1.04B
AUM Growth
+$75.5M
Cap. Flow
+$17.3M
Cap. Flow %
1.66%
Top 10 Hldgs %
56.76%
Holding
181
New
9
Increased
59
Reduced
50
Closed
18

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$5.39M
2
PJT icon
PJT Partners
PJT
+$2.61M
3
JPM icon
JPMorgan Chase
JPM
+$880K
4
CROX icon
Crocs
CROX
+$847K
5
PFE icon
Pfizer
PFE
+$580K

Sector Composition

Rank Sector Weight
1 Miscellaneous 84.71%
2 Technology 6.94%
3 Financials 4.94%
4 Consumer Discretionary 1.52%
5 Communication Services 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTPI
101
WisdomTree Equity Premium Income Fund
WTPI
$529M
$466K 0.04%
14,685
-1,631
-10% -$50.3K
VTV icon
102
Vanguard Morningstar Value ETF
VTV
$191B
$464K 0.04%
3,377
-346
-9% -$47.5K
BSV icon
103
Vanguard Short-Term Bond ETF
BSV
$46.4B
$461K 0.04%
5,610
-1
-0% -$82
DEM icon
104
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.27B
$457K 0.04%
10,010
SCHG icon
105
Schwab US Large-Cap Growth ETF
SCHG
$62B
$455K 0.04%
24,944
-3,504
-12% -$60.6K
V icon
106
Visa
V
$686B
$438K 0.04%
1,873
+19
+1% +$4.34K
XLK icon
107
State Street Technology Select Sector SPDR ETF
XLK
$122B
$433K 0.04%
5,866
+1,016
+21% +$71.2K
KMX icon
108
CarMax
KMX
$8.56B
$426K 0.04%
3,297
NFLX icon
109
Netflix
NFLX
$317B
$409K 0.04%
7,750
+1,380
+22% +$70.5K
VOE icon
110
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$402K 0.04%
2,860
HSY icon
111
Hershey
HSY
$34.6B
$395K 0.04%
2,266
-400
-15% -$67.4K
VMRK
112
Vivmark Residential
VMRK
$50.3B
$391K 0.04%
5,079
PFE icon
113
Pfizer
PFE
$158B
$389K 0.04%
9,929
-14,913
-60% -$580K
J icon
114
Jacobs Solutions
J
$16.6B
$383K 0.04%
3,469
VGK icon
115
Vanguard FTSE Europe ETF
VGK
$30.6B
$381K 0.04%
5,662
SCHV
116
Schwab US Large-Cap Value ETF
SCHV
$15.7B
$380K 0.04%
16,659
-1,455
-8% -$33K
VSS icon
117
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
$377K 0.04%
2,763
BAC icon
118
Bank of America
BAC
$438B
$372K 0.04%
9,026
+340
+4% +$13.9K
VOT icon
119
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$361K 0.03%
1,527
-18
-1% -$4.04K
VV icon
120
Vanguard Morningstar Large-Cap ETF
VV
$54B
$357K 0.03%
1,776
IVE icon
121
iShares S&P 500 Value ETF
IVE
$49.5B
$353K 0.03%
2,389
+38
+2% +$5.6K
CRM icon
122
Salesforce
CRM
$201B
$349K 0.03%
1,429
+125
+10% +$28.8K
CSCO icon
123
Cisco
CSCO
$431B
$342K 0.03%
6,457
-2,876
-31% -$151K
IBM icon
124
IBM
IBM
$226B
$340K 0.03%
2,426
-476
-16% -$65.1K
VBK icon
125
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$334K 0.03%
1,152
-5
-0.4% -$1.4K

Similar funds

Klingman & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Klingman & Associates held 181 positions worth $1.04B, up 7.8% from $967M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Klingman & Associates's Q2 2021 filing shows 9 new, 59 increased, 50 reduced and 18 closed positions. Its largest new stake was Dimensional US Targeted Value ETF: 64,917 shares worth $2.91M. The largest sale was Datadog, an estimated $5.39M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 84% a quarter earlier, followed by Technology and Financials.

  • Klingman & Associates's largest Q2 2021 buy was Dimensional US Targeted Value ETF: 64,917 shares worth $2.91M.
  • Klingman & Associates added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $5.58M increase.
  • Klingman & Associates's biggest Q2 2021 reduction was Datadog, cutting an estimated $5.39M.
  • Klingman & Associates fully exited NRC Health Common Stock in Q2 2021, selling an estimated $328K.
  • Klingman & Associates's ten largest holdings make up 57% of its $1.04B portfolio in Q2 2021.
  • Klingman & Associates opened 9 new positions and closed 18 in Q2 2021.
  • Klingman & Associates's portfolio value rose 7.8% quarter-over-quarter to $1.04B.

Based on Klingman & Associates's 13F filing for Q2 2021, filed 27 Jul 2021.